How Manufacturers Of Innovative Devices For Stroke Patients Could Benefit From EU Funding

The EU Innovative Health Initiative will soon open its doors for the latest round of applicants, with up to €40 million ($44m) available in funding for each project. But who is eligible to apply for the scheme, and where do the key opportunities for medtech lie?

Stroke Diagnosis
• Source: Shutterstock

The EU Innovative Health Initiative (IHI) has published details of 10 draft topics that are expected to be included in two upcoming calls for project proposals. For medical device and IVD manufacturers, and research organizations, some of these topics represent potential funding opportunities.

Companies that develop tools that can be used to predict, diagnose and treat people who have suffered from strokes will want to pay particular attention to the IHI over the...

What Is The IHI?

The IHI is a cross-sectoral health partnership project between the European Commission, MedTech Europe and COCIR, European Federation of Pharmaceutical Industries...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Geography

Guardant Health Launches Germline Hereditary Cancer Test

 

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.

Data Finds Capillary Blood Is A Reliable Alternative To Venous Blood For Routine Testing

 

A study from Babson Diagnostics published in the peer-reviewed Journal of Applied Laboratory Medicine showed that capillary blood sample volume issues can overcome historical challenges, such as poor quality, through a technique called assay miniaturization.

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By 

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.